Atlas Trials

Adult Angiosarcoma

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Adult Angiosarcoma

RecordFirmDate
Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma (NCT02048722)Northwestern University2014-06-13
Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery (NCT01623869)National Cancer Institute (NCI)2012-07-01
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma (NCT01532687)OHSU Knight Cancer Institute2012-03-13
Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma (NCT01462630)Fox Chase Cancer Center2011-11-03
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452)National Cancer Institute (NCI)2010-06-01
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma (NCT00720174)National Cancer Institute (NCI)2008-06-01
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma (NCT00346164)Children's Oncology Group2007-02-05
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma (NCT00245102)National Cancer Institute (NCI)2005-09-01
Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma (NCT00112463)National Cancer Institute (NCI)2005-01-07

Track Adult Angiosarcoma automatically

Every clearance here is in the API, with alerts when new ones post.